Citation
Select
Coyne KS, Paramore C, Grandy S, Mercader M, Reynolds M, Zimetbaum P
Assessing the direct costs of treating nonvalvular atrial fibrillation in the United States
Value Health. 2006 Sep-Oct;9(5):348-56
Citation
Select
A-COMET-II Investigators; Lombardi F, Borggrefe M, Ruzyllo W, L├╝deritz B
Azimilide vs. placebo and sotalol for persistent atrial fibrillation: the A-COMET-II (Azimilide-CardiOversion MaintEnance Trial-II) trial
Eur Heart J. 2006 Sep;27(18):2224-31. Epub 2006 Aug 25